A recent study demonstrated that treatment of ECs with melanoma cell-derived exosome enhanced VE-Cadherin, uPAR, and EGFR upregulation in ECs [49], resulting in a tumor EC phenotype, and through EGFR gave EGFL7 a chance to promote neoangiogenesis. The gene discussed is EGFL7; the disease is melanoma.